| Christina Cassandra Gerena, FNP-C | |
|
100 W 7th St, Okmulgee, OK 74447-5050 | |
| (918) 759-2200 | |
| Not Available |
| Full Name | Christina Cassandra Gerena |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 100 W 7th St, Okmulgee, Oklahoma |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1871246702 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 205370 (Oklahoma) | Primary |
| Entity Name | Access Medical Affordable Family Healthcare, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588995534 PECOS PAC ID: 9830229442 Enrollment ID: O20100608000729 |
News Archive
A diet high in saturated fat is a key contributor to type 2 diabetes, a major health threat worldwide. Several decades ago scientists noticed that people with type 2 diabetes have overly active immune responses, leaving their bodies rife with inflammatory chemicals.
Patients can expect significant savings and better outcomes from their prescription medications when health care professionals use comparative effectiveness research, according to researchers at the University of Illinois at Chicago.
Cornerstone Pharmaceuticals, Inc. has announced the publication of data from preclinical studies on EmPAC™, its nanoparticle reformulation of paclitaxel, in the August issue of the Journal of Nanoscience and Nanotechnology. The publication highlights data demonstrating improved safety and efficacy of EmPAC™ versus Taxol®, the generic formulation of paclitaxel and one of the most widely prescribed chemotherapies. EmPAC™ is a nanoemulsion formulation of Paclitaxel and is the lead product candidate of Cornerstone's proprietary Emulsiphan™ cancer selective delivery nanotechnology platform. Taxol®, an injectable formulation of Paclitaxel, is currently used to treat a variety of cancers, including ovarian carcinomas, breast cancer, non-small cell lung cancer, and AIDS-related Kaposi's sarcoma.
A new study has revealed that people with obstructive sleep apnoea or those who snore at night are more at risk of dementias and Alzheimer's disease.
› Verified 1 days ago
| Entity Name | Access Pain Solutions |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740535368 PECOS PAC ID: 2668620220 Enrollment ID: O20120924000708 |
News Archive
A diet high in saturated fat is a key contributor to type 2 diabetes, a major health threat worldwide. Several decades ago scientists noticed that people with type 2 diabetes have overly active immune responses, leaving their bodies rife with inflammatory chemicals.
Patients can expect significant savings and better outcomes from their prescription medications when health care professionals use comparative effectiveness research, according to researchers at the University of Illinois at Chicago.
Cornerstone Pharmaceuticals, Inc. has announced the publication of data from preclinical studies on EmPAC™, its nanoparticle reformulation of paclitaxel, in the August issue of the Journal of Nanoscience and Nanotechnology. The publication highlights data demonstrating improved safety and efficacy of EmPAC™ versus Taxol®, the generic formulation of paclitaxel and one of the most widely prescribed chemotherapies. EmPAC™ is a nanoemulsion formulation of Paclitaxel and is the lead product candidate of Cornerstone's proprietary Emulsiphan™ cancer selective delivery nanotechnology platform. Taxol®, an injectable formulation of Paclitaxel, is currently used to treat a variety of cancers, including ovarian carcinomas, breast cancer, non-small cell lung cancer, and AIDS-related Kaposi's sarcoma.
A new study has revealed that people with obstructive sleep apnoea or those who snore at night are more at risk of dementias and Alzheimer's disease.
› Verified 1 days ago
| Entity Name | Asmg Sand Springs |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902140056 PECOS PAC ID: 9739403015 Enrollment ID: O20150114001612 |
News Archive
A diet high in saturated fat is a key contributor to type 2 diabetes, a major health threat worldwide. Several decades ago scientists noticed that people with type 2 diabetes have overly active immune responses, leaving their bodies rife with inflammatory chemicals.
Patients can expect significant savings and better outcomes from their prescription medications when health care professionals use comparative effectiveness research, according to researchers at the University of Illinois at Chicago.
Cornerstone Pharmaceuticals, Inc. has announced the publication of data from preclinical studies on EmPAC™, its nanoparticle reformulation of paclitaxel, in the August issue of the Journal of Nanoscience and Nanotechnology. The publication highlights data demonstrating improved safety and efficacy of EmPAC™ versus Taxol®, the generic formulation of paclitaxel and one of the most widely prescribed chemotherapies. EmPAC™ is a nanoemulsion formulation of Paclitaxel and is the lead product candidate of Cornerstone's proprietary Emulsiphan™ cancer selective delivery nanotechnology platform. Taxol®, an injectable formulation of Paclitaxel, is currently used to treat a variety of cancers, including ovarian carcinomas, breast cancer, non-small cell lung cancer, and AIDS-related Kaposi's sarcoma.
A new study has revealed that people with obstructive sleep apnoea or those who snore at night are more at risk of dementias and Alzheimer's disease.
› Verified 1 days ago
| Entity Name | Access Solutions Medical Group Ii |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174024426 PECOS PAC ID: 4587928817 Enrollment ID: O20180514000883 |
News Archive
A diet high in saturated fat is a key contributor to type 2 diabetes, a major health threat worldwide. Several decades ago scientists noticed that people with type 2 diabetes have overly active immune responses, leaving their bodies rife with inflammatory chemicals.
Patients can expect significant savings and better outcomes from their prescription medications when health care professionals use comparative effectiveness research, according to researchers at the University of Illinois at Chicago.
Cornerstone Pharmaceuticals, Inc. has announced the publication of data from preclinical studies on EmPAC™, its nanoparticle reformulation of paclitaxel, in the August issue of the Journal of Nanoscience and Nanotechnology. The publication highlights data demonstrating improved safety and efficacy of EmPAC™ versus Taxol®, the generic formulation of paclitaxel and one of the most widely prescribed chemotherapies. EmPAC™ is a nanoemulsion formulation of Paclitaxel and is the lead product candidate of Cornerstone's proprietary Emulsiphan™ cancer selective delivery nanotechnology platform. Taxol®, an injectable formulation of Paclitaxel, is currently used to treat a variety of cancers, including ovarian carcinomas, breast cancer, non-small cell lung cancer, and AIDS-related Kaposi's sarcoma.
A new study has revealed that people with obstructive sleep apnoea or those who snore at night are more at risk of dementias and Alzheimer's disease.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christina Cassandra Gerena, FNP-C 100 W 7th St, Okmulgee, OK 74447-5050 Ph: (918) 759-2200 | Christina Cassandra Gerena, FNP-C 100 W 7th St, Okmulgee, OK 74447-5050 Ph: (918) 759-2200 |
News Archive
A diet high in saturated fat is a key contributor to type 2 diabetes, a major health threat worldwide. Several decades ago scientists noticed that people with type 2 diabetes have overly active immune responses, leaving their bodies rife with inflammatory chemicals.
Patients can expect significant savings and better outcomes from their prescription medications when health care professionals use comparative effectiveness research, according to researchers at the University of Illinois at Chicago.
Cornerstone Pharmaceuticals, Inc. has announced the publication of data from preclinical studies on EmPAC™, its nanoparticle reformulation of paclitaxel, in the August issue of the Journal of Nanoscience and Nanotechnology. The publication highlights data demonstrating improved safety and efficacy of EmPAC™ versus Taxol®, the generic formulation of paclitaxel and one of the most widely prescribed chemotherapies. EmPAC™ is a nanoemulsion formulation of Paclitaxel and is the lead product candidate of Cornerstone's proprietary Emulsiphan™ cancer selective delivery nanotechnology platform. Taxol®, an injectable formulation of Paclitaxel, is currently used to treat a variety of cancers, including ovarian carcinomas, breast cancer, non-small cell lung cancer, and AIDS-related Kaposi's sarcoma.
A new study has revealed that people with obstructive sleep apnoea or those who snore at night are more at risk of dementias and Alzheimer's disease.
› Verified 1 days ago
Jearlyn Kay Nick, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1151 S Belmont Ave, Suite 101, Okmulgee, OK 74447 Phone: 918-759-2200 Fax: 918-759-2206 | |
Amanda Lynne Doane, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1313 E 20th St, Okmulgee, OK 74447 Phone: 918-591-5700 | |
Stephanie M Moses, APRN-CNP, AGACNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1401 Dr R Alexander Dr., Okmulgee, OK 74447 Phone: 918-756-4233 | |
Shawn Lynn Howell, APRN, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 15495 N 247 Rd, Okmulgee, OK 74447 Phone: 918-733-1351 | |
Penni Young Garland, RNC, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1101 S Belmont Ave, Ste. 105, Okmulgee, OK 74447 Phone: 918-756-2533 Fax: 918-756-9588 | |
Teri M Garner, A.R.N.P. Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1313 E 20th St, Okmulgee, OK 74447 Phone: 918-758-2717 Fax: 918-756-4490 | |
Lacy Garrison, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 111 S Alabama Ave, Okmulgee, OK 74447 Phone: 918-756-2800 |